Observational studyJHEP reports : innovation in hepatology2026

Atezolizumab-bevacizumab in very elderly with hepatocellular carcinoma: Age alone is not a limiting factor except in ALBI grade 3.

Chloé Métivier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.